National Policy for Rare Diseases: Key questions explained for aspirants and aware citizens

Rare diseases affect a small percentage of the population, but collectively they impact millions. In India, the challenge is not just medical. It is economic, ethical and administrative. The National Policy for Rare Diseases (NPRD) is the government’s attempt to respond to this complex crisis.With Rare Disease Day observed every year on February 28 (February 29 in leap years), awareness around rare disorders has grown. The 2026 global theme — “More Than You Can Imagine” — highlights how rare diseases affect far more people, families and systems than statistics alone suggest.Here is a clear, exam-focused explainer in eight essential questions. What is a rare disease?There is no universally accepted definition worldwide. In India, a rare disease is generally understood as a condition affecting a very small percentage of the population, often chronic, genetic and life-threatening.Globally: The US (National Institutes of Health) defines rare diseases as those affecting fewer than 200,000 people. The EU defines them as affecting fewer than 1 in 2,000 people. India does not fix a strict numerical threshold due to lack of epidemiological data.Examples include spinal muscular atrophy, duchenne muscular dystrophy, hemophilia. Most are genetic and often require lifelong management or one-time but extremely expensive treatment. Why are rare diseases a major policy concern in India?Three hard realities:High cost of treatment (gene therapies can cost crores)Lack of awareness and late diagnosisLimited domestic drug productionFor example, gene therapy drugs for spinal muscular atrophy can cost more than Rs 10 crore per patient. This makes state support essential.For policymakers, this raises ethical questions: How should limited public funds be allocated? Should expensive treatment for a few be prioritised? What is the National Policy for Rare Diseases (NPRD)?The National Policy for Rare Diseases was notified in 2021 by the Union Ministry of Health and Family Welfare.It replaced earlier draft policies and aims to:Lower treatment costsStrengthen diagnosisPromote indigenous researchProvide financial support to eligible patientsThe policy recognises that rare diseases require long-term, structured intervention rather than ad hoc funding. How does the policy classify rare diseases?The NPRD divides rare diseases into three categories:Group 1: Diseases requiring one-time curative treatment (e.g., certain gene therapies).Group 2: Diseases needing long-term treatment but with relatively lower cost.Group 3: Diseases requiring lifelong treatment with high cost and limited therapeutic options.This classification helps prioritise funding and administrative planning. What financial assistance does the policy provide?Under the NPRD:Up to Rs 50 lakh financial support per patient is provided for treatment under certain categoriesTreatment is facilitated through designated Centres of Excellence (CoEs)However, the policy relies partly on crowd-funding mechanisms and voluntary donations, which has drawn criticism for being unpredictable. What are Centres of Excellence (CoEs)?The government has designated premier hospitals as Centres of Excellence for diagnosis and treatment.These centres:Provide advanced diagnosticsMaintain patient registriesSupport genetic counsellingAct as referral hubsThey also play a key role in building national data, something India historically lacks in rare disease management.What is the significance of Rare Disease Day 2026?Rare Disease Day is observed globally on 28 February. The 2026 theme — “More Than You Can Imagine” — emphasises:The invisible burden on familiesThe psychological and economic stressThe wider public health implicationsFor India, the day pushes governments to:Improve newborn screeningEncourage domestic manufacturing of orphan drugsInvest in gene therapy researchIt also aligns with global advocacy networks and patient rights movements. Why is the National Policy for Rare Diseases important for civil services aspirants?This topic sits at the intersection of science & technology, social justice, ethics and governance.In science & technology (GS Paper 3):Gene therapyCRISPR and biotechnologyOrphan drug developmentPublic health genomicsIn current affairs:Budgetary allocation debatesSupreme Court observations on right to healthExpansion of Centres of ExcellencePolicy revisions and implementation gapsIn governance (GS Paper 2):Centre-State coordinationHealth as a State subject with Central schemesPublic health infrastructure reformAn aspirant should understand not just what the policy says, but also:Funding sustainability issuesEthical dilemmas in resource allocationGlobal comparisonsRare diseases also connect to India’s biotech ambitions and Atmanirbhar Bharat in pharmaceuticals.Beyond policy, a test of public health prioritiesRare diseases may affect small numbers individually, but collectively they represent a serious national health burden. The National Policy for Rare Diseases is a step forward, yet implementation challenges remain.For civil services aspirants, this topic is not just about memorising policy provisions. It is about understanding how science, economics and ethics collide in public policy.Rare Disease Day 2026 reminds us that behind every statistic is a family navigating uncertainty. Effective governance means ensuring that cutting-edge science translates into accessible healthcare, not just for the many, but also for the few.In a country aspiring to global leadership in biotechnology, rare disease management will test whether innovation can truly become inclusive.Probable questions “Rare diseases highlight the intersection of science, ethics and social inequality.” Discuss in the context of India’s healthcare system.(Focus areas: economic burden on families, regional disparities in healthcare access, ethical allocation of scarce resources, genetic counselling, social stigma.)How do emerging genetic technologies and public health awareness campaigns such as Rare Disease Day influence social change in India?(Focus areas: biotechnology advances, gene therapy, awareness generation, role of civil society, demographic and social implications.)

National Policy for Rare Diseases: Key questions explained for aspirants and aware citizens

From high treatment costs to gene therapy breakthroughs, here’s what India’s rare disease framework means for patients and why it matters for civil services preparation

Ivninder Pal Singh

Tribune News Service

National Policy for Rare Diseases: Key questions explained for aspirants and aware citizens

From high treatment costs to gene therapy breakthroughs, here’s what India’s rare disease framework means for patients and why it matters for civil services preparation

Ivninder Pal Singh

Tribune News Service

Unlock Premium Insights in This Article